David A. Ramsay

2009

In 2009, David A. Ramsay earned a total compensation of $437.3K as Vice President Corporate Development at Halozyme Therapeutics, a 23% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$54,000
Option Awards$105,567
Salary$270,000
Other$7,746
Total$437,313

Ramsay received $270K in salary, accounting for 62% of the total pay in 2009.

Ramsay also received $54K in non-equity incentive plan, $105.6K in option awards and $7.7K in other compensation.

Rankings

In 2009, David A. Ramsay's compensation ranked 7,300th out of 9,885 executives tracked by ExecPay. In other words, Ramsay earned more than 26.2% of executives.

ClassificationRankingPercentile
All
7,300
out of 9,885
26th
Division
Manufacturing
2,711
out of 3,690
27th
Major group
Chemicals And Allied Products
608
out of 866
30th
Industry group
Drugs
426
out of 638
33rd
Industry
Biological Products, Except Diagnostic Substances
79
out of 133
41st
Source: SEC filing on April 1, 2010.

Ramsay's colleagues

We found eight more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2009.

2009

Jonathan Leff

Halozyme Therapeutics

Chief Medical Officer

2009

Kurt Gustafson

Halozyme Therapeutics

Chief Financial Officer

2009

Jonathan Lim

Halozyme Therapeutics

Chief Executive Officer

2009

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

2009

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

2009

William Fallon

Halozyme Therapeutics

Vice President, Manufacturing & Operations

2009

Robert Little

Halozyme Therapeutics

Vice President and Chief Commercial Officer

2009

Michael LaBarre

Halozyme Therapeutics

Vice President, Product Development

You may also like